Search

Meet the four young ambassadors featured in the annual Stop & Shop campaign to fundraise for the Department of Pediatrics at Memorial Sloan Kettering.

… Monday, June 11, 2018 Summary For nearly 20 years, Memorial Sloan Kettering has partnered with Stop & Shop supermarkets to raise funds for pediatric cancer research. Meet the four spunky kids representing MSK across New York, New Jersey, and Connecticut for this year’s campaign. The next time you visit

A phase 3 trial for myelofibrosis found that adding pelabresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.

… Tuesday, April 29, 2025 An international phase 3 clinical trial of a new drug combination for treating the blood cancer  myelofibrosis found that adding a second, experimental drug to standard treatment was more effective than the standard treatment alone. Further, adding the second drug did not significantly

New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.

… Thursday, February 27, 2014 New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain. Published in the February 27 issue of Cell , the study found that tumor cells that reach the brain — and successfully

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.

… Monday, July 15, 2024 There’s a frustrating fact about today’s immunotherapies for cancer . While sometimes they work beautifully — completely eliminating or greatly reducing cancer in particular patients — other times they don’t work at all. It’s a mystery. Scientists have posed several hypotheses to

Learn how the Head and Neck Cancer Service at MSK helps people overcome a variety of cancers while preserving facial appearance and function.

… Thursday, September 11, 2025 James Mangan is a world-class rowing coach who has led elite teams in his native Ireland and in the United States all the way to the Olympics. So when he learned he had a serious skin cancer, he was concerned not only for his health but for his ability to continue the work

How does being lesbian, gay, bisexual, or transgender affect your risk of getting cancer? Good question.

… Friday, February 19, 2016 Summary A new policy paper authored by MSK clinicians and patient advocates draws attention to the need for collecting comprehensive data to understand how cancer affects lesbian, gay, bisexual, and transgender people. Until these data are collected, we won’t know for sure the

The discovery links metabolism to the way cancer stem cells form tumors.

… Tuesday, May 26, 2020 Summary A team of scientists at the Sloan Kettering Institute and The Rockefeller University has discovered that cancer stem cells rely on a steady external supply of the amino acid serine. This dependency makes them vulnerable to restrictions on this supply, a discovery that could

Learn about a potential new strategy for treating people with blood cancers such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) that targets a protein on cancer stem cells.

… Thursday, February 2, 2017 Summary Blood cancers such as acute myeloid leukemia and myelodysplastic syndrome often come back after initial treatment, which researchers suspect is caused by stem cells that are never wiped out and go on to initiate and sustain the disease again. It has now been discovered

Researchers have discovered how a high level of the protein PSMA in cells helps fuel prostate cancer.

… Wednesday, November 15, 2017 Summary Prostate cancer cells have high levels of prostate-specific membrane antigen (PSMA), but researchers were unsure of its biological role. Now an MSK-led team has discovered that PSMA contributes to prostate cancer’s development. This offers a new target for drugs.

A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.

… Thursday, July 12, 2018 A natural killer cell (top right) attacks and kills a cancer cell (center), which blebs and spills its contents. Video courtesy of Morgan Huse. Summary Scientists are coming to appreciate the importance of a specific type of immune cell that keeps people free from disease. Most